Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB/ SE0000872095 /
BIOVF
2024-04-18 7:26:21 PM
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
22.8700USD
|
-
|
3,000 Turnover: 70,772.5000 |
-Bid Size: - |
-Ask Size: - |
9.31 bill.USD |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
7.47 SEK |
-16.26% |
EPS Diluted: |
- SEK |
-16.40% |
Revenues per Share: |
62.43 SEK |
2.93% |
Book Value per Share: |
95.57 SEK |
11.63% |
Cash Flow per Share: |
12.61 SEK |
-16.23% |
Dividend per Share: |
- SEK |
- |
Total |
in mill. |
|
Revenues: |
22,123.00 SEK |
17.74% |
Net Income: |
2,409.00 SEK |
-8.68% |
Operating Cash Flow: |
4,470.00 SEK |
- |
Cash and Cash Equivalents: |
904.00 SEK |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
37.91 |
35.74 |
P/S Ratio: |
4.54 |
4.28 |
P/BV ratio: |
2.96 |
2.79 |
P/CF Ratio: |
22.45 |
21.17 |
PEG: |
-2.33 |
-2.20 |
Earnings Yield: |
2.64% |
2.80% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
9.31 bill. USD |
9.38 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
5.25 mill. USD |
5.29 mill. USD |
Shares Outstanding: |
354.36 mill. |
|
Profitability
Gross Profit Margin: |
77.42% |
EBIT Margin: |
18.38% |
Net Profit Margin: |
10.89% |
Return on Equity: |
7.11% |
Return on Assets: |
3.25% |
Financial Strength
Liquidity I / Cash Ratio: |
4.73% |
Liquidity II / Quick Ratio: |
31.80% |
Liquidity III / Current Ratio: |
66.36% |
Debt / Equity Ratio: |
118.58% |
Dynam. Debt / Equity Ratio: |
898.43% |
Efficiency
Employees: |
1,772 |
Personal Expenses / Employee: |
- SEK |
Revenues / Employee: |
12,484,762.98 SEK |
Net Income / Employee: |
1,359,480.81 SEK |
Total Assets / Employee: |
41,775,959.37 SEK |
* Fiscal Year End: |
2023-12-31 |
Accounting Standard: |
IFRS |